Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
Butterfly Network Q2 revenue beats on strong U.S. demand

Butterfly Network Q2 revenue beats on strong U.S. demand

ReutersReuters2026/07/30 10:41
By:Reuters


Overview

  • U.S. ultrasound device maker's Q2 revenue grew 39% yr/yr, beating analyst expectations

  • Adjusted loss per share for Q2 beat analyst expectations

  • Company raised full-year revenue and adjusted EBITDA guidance


Outlook

  • Butterfly Network raises 2026 revenue guidance to $119 mln-$123 mln, up 22%-26%

  • Company expects Q3 2026 revenue of $26 mln-$30 mln, about 30% growth at midpoint

  • Company expects first Home Community Care commercial revenue in Q4 2026


Result Drivers

  • U.S. REVENUE GROWTH - Company said U.S. revenue rose 57% yr/yr, driven by Embedded partnerships and increased probe sales to health systems, medical schools, and eCommerce customers

  • GROSS MARGIN EXPANSION - Gross margin rose to 71.4%, mainly due to higher-margin Embedded licensing revenue and reduced software amortization costs

  • INTERNATIONAL REVENUE DECLINE - International revenue fell 14% yr/yr, largely due to decreased probe sales to international distribution partners, partly offset by commercial expansion into Brazil


Company press release: ID:nBw4skbJJa


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Revenue

Beat

$32.60 mln

$29.36 mln (5 Analysts)

Q2 Adjusted Loss Per Share

Beat

$0.01

$0.06 (4 Analysts)

Q2 Loss Per Share

$0.05

Q2 Net Loss

$12.90 mln

Q2 Adjusted EBITDA

-$1.40 mln


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the advanced medical equipment technology peer group is "buy"

  • Wall Street's median 12-month price target for Butterfly Network Inc is $6.00, about 15.5% below its July 29 closing price of $7.10


Reuters Recommended Reads

  • July 29 - GE HealthCare tops quarterly estimates, weighs patient care unit sale

  • July 29 - Glaukos Q2 sales jump 50%; raises net sales forecast

  • July 29 - Bausch + Lomb Q2 revenue beats on surgical segment growth; lifts outlook


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!